Combination therapy helps keep patients with COPD out of hospitalBMJ 2007; 334 doi: https://doi.org/10.1136/bmj.334.7599.873-c (Published 26 April 2007) Cite this as: BMJ 2007;334:873
Anticholinergic bronchodilators, long acting β2 agonists, and inhaled corticosteroids are the mainstays of treatment for people with chronic obstructive pulmonary disease (COPD). Many patients use combinations of all three. Good evidence to support any combination is hard to come by, partly because …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial